Marketdash
Back to News

Analysts Boost Price Targets on Legence Following Mixed Q3 Results and Major Acquisition

MarketDash Editorial Team
20 days ago
Legence Corp reported mixed Q3 earnings with revenue beating expectations but earnings missing forecasts. Despite the miss, analysts raised their price targets following the company's announcement of a $475 million acquisition and strong forward guidance.

Legence Corp (LGN) delivered a tale of two quarters on Friday—revenue crushing expectations while earnings fell short. The kind of mixed results that make analysts pause, recalculate, and apparently decide the story is actually pretty good.

The company reported third-quarter revenue of $708.01 million, jumping 26.2% year-over-year and sailing past the $639.78 million analysts had penciled in. That's the good news. The not-so-good news? Legence posted an earnings per share loss of 2 cents, missing consensus estimates that had called for a 6-cent profit. Gross margin also slipped slightly to 20.9% from 21.1% the previous year.

But here's where things get interesting. Legence simultaneously announced it's acquiring The Bowers Group for approximately $475 million—a deal structured as $325 million in cash, $100 million in stock, and $50 million in deferred consideration payable in cash or stock by the end of 2026. That's a significant bet on future growth.

The forward-looking guidance seems to justify the optimism. For the fourth quarter, Legence expects revenue between $600 million and $630 million, with the midpoint comfortably above the consensus estimate of $608.45 million. Adjusted EBITDA is projected at $60 million to $65 million.

Looking further ahead to fiscal 2026, the company projects revenue of $2.65 billion to $2.85 billion—notably above the consensus of $2.63 billion—with adjusted EBITDA between $295 million and $315 million.

Investors seemed to like what they heard. Legence shares climbed 3.7% to $41.77 on Monday.

The analyst community responded with a round of price target increases, even after the earnings miss:

  • BMO Capital analyst Devin Dodge maintained an Outperform rating and raised the price target from $36 to $46.
  • RBC Capital analyst Sabahat Khan kept an Outperform rating while boosting the target from $36 to $48.
  • Goldman Sachs analyst Adam Bubes maintained a Buy rating and increased the price target from $37 to $46.
  • Barclays analyst Adam Seiden held an Equal-Weight rating but raised the target from $34 to $37.

The takeaway? Sometimes it's not about the quarter you just reported—it's about the story you're telling for the quarters ahead.

Back to News

Analysts Boost Price Targets on Legence Following Mixed Q3 Results and Major Acquisition

MarketDash Editorial Team
20 days ago
Legence Corp reported mixed Q3 earnings with revenue beating expectations but earnings missing forecasts. Despite the miss, analysts raised their price targets following the company's announcement of a $475 million acquisition and strong forward guidance.

Legence Corp (LGN) delivered a tale of two quarters on Friday—revenue crushing expectations while earnings fell short. The kind of mixed results that make analysts pause, recalculate, and apparently decide the story is actually pretty good.

The company reported third-quarter revenue of $708.01 million, jumping 26.2% year-over-year and sailing past the $639.78 million analysts had penciled in. That's the good news. The not-so-good news? Legence posted an earnings per share loss of 2 cents, missing consensus estimates that had called for a 6-cent profit. Gross margin also slipped slightly to 20.9% from 21.1% the previous year.

But here's where things get interesting. Legence simultaneously announced it's acquiring The Bowers Group for approximately $475 million—a deal structured as $325 million in cash, $100 million in stock, and $50 million in deferred consideration payable in cash or stock by the end of 2026. That's a significant bet on future growth.

The forward-looking guidance seems to justify the optimism. For the fourth quarter, Legence expects revenue between $600 million and $630 million, with the midpoint comfortably above the consensus estimate of $608.45 million. Adjusted EBITDA is projected at $60 million to $65 million.

Looking further ahead to fiscal 2026, the company projects revenue of $2.65 billion to $2.85 billion—notably above the consensus of $2.63 billion—with adjusted EBITDA between $295 million and $315 million.

Investors seemed to like what they heard. Legence shares climbed 3.7% to $41.77 on Monday.

The analyst community responded with a round of price target increases, even after the earnings miss:

  • BMO Capital analyst Devin Dodge maintained an Outperform rating and raised the price target from $36 to $46.
  • RBC Capital analyst Sabahat Khan kept an Outperform rating while boosting the target from $36 to $48.
  • Goldman Sachs analyst Adam Bubes maintained a Buy rating and increased the price target from $37 to $46.
  • Barclays analyst Adam Seiden held an Equal-Weight rating but raised the target from $34 to $37.

The takeaway? Sometimes it's not about the quarter you just reported—it's about the story you're telling for the quarters ahead.

    Analysts Boost Price Targets on Legence Following Mixed Q3 Results and Major Acquisition - MarketDash News